Chronically elevated levels of circulating BCAAs are known to be a propagating factor for cardiac hypertrophy, muscle lipid accumulation, hepatic lipid storage, and glycemia, which contribute to various metabolic disorders. Ramino-Bio is developing a drug for lowering elevated BCAA levels.

link to Ramino Bio page

 Maple syrup urine disease, Heart failure with preserved ejection fraction

Prof. Yibin Wang, Inventor

Dorit Cohen-Carmon, PhD, CSO